why have i not lost weight on semaglutide am losing (Ozempic/Wegovy)? Why Am I Not Losing
Description
Foundayo (Orforglipron) Foundayo represents the newest class of FDA-approved oral GLP-1 medications for weight loss, notable for its flexibility in dosing without food or water requirements

Hes been trying to figure out how these popular medications impact oral health

GLP-1R activation is neuroprotective in cellular and animal models of dopaminergic degeneration (Jones-Tabah, 2022)

Patients often report quieter snoring, fewer choking or gasping episodes, and an easier time breathing throughout the night
Mucosal barrier limitation Mucosa, as the first line of defense of the immune system in organisms, has multiple barrier functions, including physical barriers, biochemical barriers and microbial barriers, etc

This difference primarily stems from bioavailability: injectable semaglutide enters circulation directly, while oral semaglutide faces significant absorption challenges in the digestive tract